Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XCF2 | ISIN: US09062W2044 | Ticker-Symbol: BJX1
Frankfurt
27.06.25 | 08:00
18,200 Euro
+0,55 % +0,100
1-Jahres-Chart
BIOLIFE SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
BIOLIFE SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
18,40018,80028.06.
18,30018,40027.06.

Aktuelle News zur BIOLIFE SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.05.BIOLIFE SOLUTIONS INC - 10-Q, Quarterly Report1
08.05.BIOLIFE SOLUTIONS INC - 8-K, Current Report-
08.05.BioLife Solutions, Inc.: BioLife Solutions Reports First Quarter 2025 Financial Results70Cell Processing revenue of $21.6 million, up 33% over Q1 2024 GAAP gross margin of 63% and non-GAAP adjusted gross margin of 66% GAAP net loss of $0.4 million and...
► Artikel lesen
10.04.BioLife Solutions Buying Cryopreservation Solutions Company PanTHERA CryoSolutions1
08.04.BIOLIFE SOLUTIONS INC - 10-K/A, Annual Report1
07.04.BioLife Solutions Acquires PanTHERA CryoSolutions To Enhance Biopreservation For CGT1
07.04.BioLife Solutions acquires PanTHERA CryoSolutions1
BIOLIFE SOLUTIONS Aktie jetzt für 0€ handeln
07.04.BioLife Solutions, Inc.: BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company135Strategic acquisition enhances biopreservation media portfolio with novel Ice Recrystallization Inhibitor technology Marks the second acquisition from Bioproduction...
► Artikel lesen
24.03.BIOLIFE SOLUTIONS INC - 8-K, Current Report1
03.03.BIOLIFE SOLUTIONS INC - 10-K, Annual Report1
03.03.BioLife Solutions projects $95.5M-$99M revenue for 2025 with 16%-20% growth2
03.03.BioLife Solutions beats top-line and bottom-line estimates; initiates FY25 outlook3
03.03.BIOLIFE SOLUTIONS INC Q4 Earnings Summary1
03.03.BIOLIFE SOLUTIONS INC - 8-K, Current Report-
03.03.BioLife Solutions, Inc.: BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results164Cell Processing revenue up 7% sequentially to $20.3 million in the fourth quarter; 2024 Cell Processing revenue up 12% over prior year to $73.5 million GAAP gross...
► Artikel lesen
28.02.BioLife Solutions Q4 2024 Earnings Preview2
13.01.BioLife Solutions Q4 prelim revenue was $22.7M, up 31%2
13.01.BioLife Solutions, Inc.: BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations181Fourth quarter Cell Processing revenue increased 7% sequentially to $20.3 million Unaudited revenue for FY2024 from Cell Processing of $73.5 million, exceeded the...
► Artikel lesen
13.01.BIOLIFE SOLUTIONS INC - 8-K, Current Report-
12.11.24BioLife Solutions, Inc.: BioLife Solutions Reports Third Quarter 2024 Financial Results167Cell Processing revenue grew 6% sequentially to $19.0 million; 43% increase compared to 2023 GAAP gross margin of 51% and non-GAAP adjusted gross margin of 54% GAAP...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1